Position in BMEA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$137,822
+$21,943 QoQ
Shares Held
93,757
+23.8% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 61 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMEA Over Time
Shares Held
Position Value (USD)
Derivatives in BMEA
reported options exposure · as of Sep 30, 2023CallValue
$576,544
CallShares
41,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. BMEA ranks #326 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in BMEA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,822 | 93,757 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $115,879 | 75,739 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $85,306 | 68,796 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $537,357 | 266,019 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $354,777 | 197,099 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $218,309 | 102,493 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $403,251 | 103,931 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,030,573 | 102,037 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $443,533 | 98,563 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,202,061 | 347,964 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,495,813 | 171,888 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $576,544 | 41,900 | Call | Defined | 2024-05-15 | |
| 2023-09-30 | $1,318,882 | 95,849 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $919,705 | 41,900 | Call | Defined | 2024-05-14 | |
| 2023-06-30 | $2,171,951 | 98,950 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,962,757 | 95,542 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $281,663 | 33,412 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $189,291 | 19,355 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $218,467 | 18,236 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $115,010 | 25,787 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $148,508 | 19,934 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||